Nourish Lands $70M to Fight Chronic Disease with Nutrition Care
Nourish's Series B round was led by J.P. Morgan Private Capital’s Growth Equity Partners. In total, the company has raised $115 million.
Food as Health: Shifting from Treatment to Prevention of Diet-Related Disease
Overcoming the systemic, structural and cultural issues that lead to poor nutrition is complex, making it even more essential for both private and public investment in food as health programs and policies that have been shown to be effective.
presented by
How to Optimize Your Phlebotomy Setup for Efficient Patient Care
The layout of your phlebotomy station can significantly impact efficiency. A well-thought-out setup ensures that every tool is within reach, minimizing unnecessary movement and reducing patient wait times.
Twin Health Snags $50M to Help Employers, Health Plans Treat Metabolic Disease
Twin Health raked in $50 million in Series D financing. The startup seeks to help patients improve their metabolic health and reduce the need for medications through the “digital twin” technology it sells to employers and health plans.
Patients Are More Likely To Get Cancer Screenings Once on Medicare, Report Finds
For breast cancer, 20.5% of patients received a screening in the year prior to being on Medicare, compared to 30.4% in the first year of being on Medicare, according to an Epic Research report. For colorectal cancer, screening rates jumped from 6% in the year before being on Medicare to 11% in the first year of being on Medicare.
Lark Health nabs $100M to pour into AI health coaching platform
The company, which offers an AI platform that provides personalized health coaching for chronic disease patients, will use the new funds to invest in research and development and to expand its virtual integrations with health plans and employers.
With FDA nod, ChemoCentryx pill stands out in a sea of injectable & infused meds
ChemoCentryx has spent decades developing oral alternatives to injectable and infused biologic drugs that treat chronic autoimmune conditions. The research finally paid off with FDA approval of Tavneos, a ChemoCentryx pill for a rare autoimmune disease.
presented by
5 Major Trends Emerging in Healthcare Benefits in 2025
Employees who enjoy their benefits are more inclined to stay with their company. A 2025 Marsh McLennan Agency report said 73% of employees would remain if plan options were better.
ChristianaCare added a primary care practice to its cancer center. Here’s why.
When ChristianaCare's Graham Cancer Center saw that a significant number of its patients did not have a primary care provider, they decided to take action. Now, any patient that doesn't already have a PCP is connected to one onsite at the cancer center, expanding the care each patient receives.
How Jefferson Health is caring for chronic disease patients amid a pandemic
Providing care for chronic disease patients during a one-in-a-century pandemic is full of challenges, but health systems like Jefferson Health are finding ways — with help from technology — to make sure their patients are getting the care they need.
Attention digital health startups: MedCity’s next pitch competition is looking for applicants
The MedCity INVEST Digital Health Virtual event, Sep 21-25 will spotlight healthcare startups in four categories. The application deadline is August 14 at 5pm ET.
Five tidbits and takeaways from Livongo’s IPO filing
The chronic disease management company filed its S-1 paperwork on Friday, joining Change Healthcare, Phreesia and Health Catalyst as part of the raft of companies planning to go public after a nearly three year IPO drought in digital health.
presented by
The Top-Rated Orthopedic Surgery Centers in the Houston Area and Beyond
Discover Houston's best orthopedic surgery centers and what features — from personalized treatment plans to rehabilitation services — make these top providers stand out in their industry.